{"url":"https://whatshealthyandwhy.com/pine-bark-extract/antioxidant-and-vascular-health","path":"/pine-bark-extract/antioxidant-and-vascular-health","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/pine-bark-extract/antioxidant-and-vascular-health.json","markdown":"https://whatshealthyandwhy.com/pine-bark-extract/antioxidant-and-vascular-health.md"},"topic":{"slug":"pine-bark-extract","name":"Pine Bark Extract","url":"https://whatshealthyandwhy.com/pine-bark-extract"},"slug":"antioxidant-and-vascular-health","order":1,"title":"Antioxidant Protection and Vascular Health","question":"Does Pycnogenol pine bark extract help heart health and blood sugar?","answer":"Pine bark extract (Pycnogenol) likely lowers blood sugar and HbA1c slightly and improves blood-vessel function, based on a 24-trial meta-analysis and small trials.","description":"How Pycnogenol, a potent plant antioxidant from French maritime pine bark, supports cardiovascular function, circulation, and cognitive health","confidence":3,"confidenceNote":"A meta-analysis of 24 RCTs (1,594 people) found small glucose and HbA1c drops; vascular and cognitive effects rest on small trials, two without placebo.","evidenceSummary":{"rctCount":3,"observationalCount":0,"metaAnalysisCount":1,"totalParticipants":"2,000+","replicated":true,"newestStudyYear":2024},"category":{"categoryTitle":"What's Good For You","categorySlug":"good-for-you","subcategoryName":"Supplements & Vitamins","subcategorySlug":"supplements","url":"https://whatshealthyandwhy.com/explore/good-for-you/supplements"},"actions":["Take 100–200 mg a day, the range used in most trials, for 8–12 weeks before judging results.","Choose the standardized branded extract (Pycnogenol, 65–75% procyanidins); generic pine bark extracts vary widely in potency."],"cautions":["It may enhance blood-thinning medications; talk to a doctor if you take anticoagulants or anti-platelet drugs.","Mild stomach upset or nausea occurs in a small minority of users.","Cognitive benefits come from two small trials without placebo controls [4][5]."],"simpleText":"Pine bark extract — sold most commonly as Pycnogenol — is a standardized concentrate from the bark of the French maritime pine tree (Pinus pinaster). It contains a dense mixture of antioxidant compounds called oligomeric proanthocyanidins (OPCs) alongside phenolic acids and taxifolin. Over 30 years of research have examined its effects on blood vessel health, circulation, inflammation, blood sugar, and cognitive function [1][6]. It stands out for the sheer breadth of conditions studied in clinical trials — not just test tubes.","mediumText":"How Pine Bark Extract Works\n\nThe Active Compounds\n\nPycnogenol is standardized to contain 65–75% procyanidins — the same class of antioxidants found in grape seed extract, dark chocolate, and red wine, but in a more concentrated form. These OPCs neutralize free radicals, reduce oxidative stress in blood vessel walls, and modulate key inflammatory signaling pathways including NF-κB [6].\n\nThe extract also contains caffeic acid, ferulic acid, and taxifolin, which contribute to its anti-inflammatory and endothelium-protective effects. After oral ingestion, OPCs are metabolized by gut bacteria into smaller phenolic acids that circulate in the bloodstream — meaning the gut microbiome plays a role in how well the extract works for each person.\n\nVascular and Cardiovascular Effects\n\nPine bark extract's most consistent research is in cardiovascular health. It works through three main mechanisms:\n\nNitric oxide production: Pycnogenol stimulates endothelial nitric oxide synthase (eNOS), which produces nitric oxide (NO) — the molecule that relaxes blood vessel walls and regulates blood pressure. This is one reason it improves blood flow and lowers blood pressure in hypertensive individuals.\n\nOxidative stress reduction: OPCs scavenge free radicals directly in the endothelium (the inner lining of blood vessels), reducing lipid peroxidation and the oxidation of LDL cholesterol — a key step in atherosclerosis formation.\n\nAnti-platelet activity: Pycnogenol reduces platelet aggregation, which decreases the tendency of blood to clot inappropriately. Studies on long-distance airline travelers have shown it reduces the risk of deep vein thrombosis [6].\n\nBlood Sugar and Metabolic Health\n\nPycnogenol inhibits alpha-glucosidase — an enzyme in the gut that breaks carbohydrates down into glucose — slowing the post-meal glucose spike. It also improves insulin sensitivity through antioxidant reduction of inflammation in fat tissue. A 2019 meta-analysis of 24 RCTs found supplementation significantly reduced fasting blood glucose and hemoglobin A1c [2].\n\nCognitive and Brain Effects\n\nThe brain is metabolically demanding and highly sensitive to oxidative damage and poor blood flow. Pycnogenol's neuroprotective effects appear to come from both direct antioxidant action in the brain and improved cerebrovascular circulation — delivering more oxygen and nutrients to neurons. Multiple clinical trials show measurable improvements in attention, working memory, and mental speed [4][5].\n\nDosage and Safety\n\n- Clinical research doses: Most trials use 100–200 mg/day; cognitive studies often use 100–150 mg/day\n- Duration: Benefits accumulate over 4–12 weeks; most trials run 8–12 weeks\n- Safety: Over 30 years of use and multiple safety reviews show a good profile — mild GI symptoms (nausea, stomach upset) in a small minority; generally well-tolerated\n- Interactions: May enhance blood-thinning medications; consult a doctor if taking anticoagulants or anti-platelet drugs\n- What to look for: \"Pycnogenol\" is a registered trademark with standardized OPC content; generic pine bark extracts vary widely in potency\n\nFor related vascular support, see our Nattokinase page and Omega-3 page.","deepText":"Evidence Review\n\nOverview: 39 Randomized Controlled Trials\n\nThe most comprehensive synthesis of Pycnogenol research to date is the 2024 review by Weichmann and Rohdewald (PMID 38757130), published in Frontiers in Nutrition. It identified 39 randomized, double-blind, placebo-controlled trials involving 2,009 participants with supplementation periods ranging from 2 weeks to 6 months. Domains showing statistically significant benefit across multiple trials included: cardiovascular health, chronic venous insufficiency, cognition, joint health, skin health, eye health, women's health (menopausal symptoms, dysmenorrhea), respiratory health, and sports performance. This breadth of effect across well-designed trials is unusual for any single supplement.\n\nCardiovascular: Endothelial Function in Coronary Artery Disease\n\nEnseleit et al. (2012, European Heart Journal) conducted a double-blind, randomized, placebo-controlled crossover study in 23 patients with stable coronary artery disease — a population where endothelial dysfunction is central to disease progression [3]. Patients received 200 mg/day of Pycnogenol for 8 weeks on top of standard cardiovascular therapy, with a 2-week washout between periods. Pycnogenol improved brachial artery flow-mediated dilation (FMD), a standard non-invasive measure of endothelial function, from 5.3% to 7.0% (P < 0.0001), while FMD did not improve with placebo (estimated treatment effect 2.75 percentage points, 95% CI 1.75 to 3.75). The oxidative-stress marker 15-F2t-isoprostane also fell significantly with Pycnogenol (0.71 to 0.66; P = 0.012), whereas inflammation markers, platelet adhesion, and blood pressure did not change. The authors concluded that Pycnogenol improves endothelial function in coronary artery disease patients by reducing oxidative stress. The crossover design and a population of actual CAD patients on standard therapy make this clinically relevant, but the study was small.\n\nCardiometabolic: Meta-Analysis of 24 RCTs\n\nMalekahmadi et al. (PMID 31585179) pooled data from 24 randomized controlled trials with 1,594 total participants, published in Pharmacological Research in 2019. Key findings:\n\n- Fasting blood glucose: Significant reduction (weighted mean difference approximately −5.86 mg/dL; p < 0.05)\n- HbA1c: Significant reduction (−0.29%; p < 0.05)\n- LDL cholesterol: Modest but significant reduction in several subgroup analyses\n- Blood pressure: Some reductions in systolic and diastolic pressure, particularly in hypertensive subgroups\n\nHeterogeneity across trials was moderate, which is expected given the variety of populations and dosages studied. Subgroup analyses consistently showed larger effects in diabetic populations and those with elevated baseline cardiometabolic risk markers, suggesting Pycnogenol may be most useful as a complement to lifestyle interventions in metabolic disease.\n\nCognitive Function: Working Professionals\n\nBelcaro et al. (PMID 24675223) enrolled 60 healthy professionals aged 35–55 with elevated oxidative stress markers in a 12-week product-evaluation study comparing Pycnogenol (150 mg/day) to no supplementation. Cognitive assessment used validated tests including PASAT (sustained attention), pattern recognition memory, spatial recognition memory, and spatial working memory. The Pycnogenol group showed statistically significant improvements in spatial working memory, sustained attention, and overall composite cognitive score. Additionally, the researchers assessed 12 specific professional daily tasks (concentration on projects, managing assignments, time scheduling, etc.) — all 12 items showed measurable improvement in the supplemented group. Mood parameters including alertness and anxiety also improved.\n\nThis was not a blinded placebo-controlled trial (a limitation), but the objective cognitive test battery provides credible evidence beyond self-report. The working-professional population (not elderly or cognitively impaired) suggests a real-world performance benefit for normal-functioning adults.\n\nCognitive Function: Minimal Cognitive Impairment\n\nHosoi, Belcaro et al. (PMID 29754480), published in the Journal of Neurosurgical Sciences in 2018, studied 87 otherwise healthy subjects with mild cognitive impairment (MMSE scores 18–23, BMI <26, no metabolic disorders). Forty-three received Pycnogenol 150 mg/day plus standard management for 8 weeks; 44 received standard management only. The Pycnogenol group showed significant improvement in MMSE scores, cognitive test performance, and oxidative stress markers (plasma free radicals, protein carbonyls). The effect was attributed to reduced neuroinflammation and improved cerebral blood flow. This population is closer to the clinical question of whether supplementation can meaningfully support early cognitive decline — and the results suggest it can.\n\nFoundational Pharmacology\n\nRohdewald's 2002 review (PMID 11996210) in International Journal of Clinical Pharmacology and Therapeutics remains the foundational pharmacological summary of Pycnogenol. It documents the extract's absorption kinetics (OPCs are absorbed within 20 minutes and reach peak plasma concentration within 1–2 hours), its inhibition of NF-κB, ACE inhibition (mechanism for blood pressure reduction), and inhibition of histamine release from mast cells. This review established that Pycnogenol's effects stem from multiple simultaneous mechanisms rather than a single pathway — which helps explain its consistent effects across diverse clinical endpoints.\n\nEvidence Strength Assessment …","deepTruncated":true,"references":[{"id":"1","title":"Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies","authors":"Weichmann F, Rohdewald P","year":2024,"journal":"Frontiers in Nutrition","pmid":"38757130","url":"https://pubmed.ncbi.nlm.nih.gov/38757130/"},{"id":"2","title":"Effects of pycnogenol on cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials","authors":"Malekahmadi M, Moradi Moghaddam O, Firouzi S, Daryabeygi-Khotbehsara R, Shariful Islam SM, Norouzy A, Soltani S","year":2019,"journal":"Pharmacological Research","pmid":"31585179","url":"https://pubmed.ncbi.nlm.nih.gov/31585179/"},{"id":"3","title":"Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study","authors":"Enseleit F, Sudano I, Periat D, Winnik S, Wolfrum M, Flammer AJ, Fröhlich GM, Kaiser P, Hirt A, Haile SR, Krasniqi N, Matter CM, Uhlenhut K, Högger P, Neidhart M, Lüscher TF, Ruschitzka F, Noll G","year":2012,"journal":"European Heart Journal","pmid":"22240497","url":"https://pubmed.ncbi.nlm.nih.gov/22240497/"},{"id":"4","title":"Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55","authors":"Belcaro G, Luzzi R, Dugall M, Ippolito E, Saggino A","year":2014,"journal":"Journal of Neurosurgical Sciences","pmid":"24675223","url":"https://pubmed.ncbi.nlm.nih.gov/24675223/"},{"id":"5","title":"Pycnogenol® supplementation in minimal cognitive dysfunction","authors":"Hosoi M, Belcaro G, Saggino A, Luzzi R, Dugall M, Feragalli B","year":2018,"journal":"Journal of Neurosurgical Sciences","pmid":"29754480","url":"https://pubmed.ncbi.nlm.nih.gov/29754480/"},{"id":"6","title":"A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology","authors":"Rohdewald P","year":2002,"journal":"International Journal of Clinical Pharmacology and Therapeutics","pmid":"11996210","url":"https://pubmed.ncbi.nlm.nih.gov/11996210/"}],"wordCount":1324,"source":{"path":"src/content/topics/pine-bark-extract/antioxidant-and-vascular-health.md"},"citeAs":"“Does Pycnogenol pine bark extract help heart health and blood sugar?.” What's Healthy and Why. https://whatshealthyandwhy.com/pine-bark-extract/antioxidant-and-vascular-health","notice":"General information backed by peer-reviewed research, not medical advice."}